Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML projectClaudia Sargas, Pau Montesinos, Estrella Carrillo‐Cruz et al.|Haematologica|2020Cited by 37
Do NPM1 and FLT3-ITD mutations modify prognosis in patients treated with non-intensive regimens?Edwin Uriel Suárez, Blanca Boluda, Esperanza Lavilla et al.|Annals of Hematology|2024Cited by 1